Bloodwork question about oxiracetam. Baseline, two months in, and the numbers moved in a direction I did not expect.
What surprised me is how much of the perceived benefit was routine and attention rather than pharmacology.
The effect size I actually noticed is roughly a third of what the write-ups imply, and it took two months to be sure.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
Would like a narrow answer rather than an enthusiastic one.
Narrow conclusion.
How long before you can reasonably say something is or is not doing anything? Headaches was my main issue with oxiracetam too.
Stupid question: how do you know whether what is in the vial matches the label at all? Two months in on oxiracetam and it lines up.